Source document
Loading sections…
Sections in this filing
MD&A
Item 7.01 Regulation FD Disclosure. On July 29, 2026, SiriusPoint Ltd. made available to investors its second quarter financial supplement attached hereto as Exhibit 99.2 and slide presentation attached hereto as Exhibit 99.3. The information contained in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.2 and Exhibit 99.3 attached hereto, are being furnished pursuant to this Item 7.01. This information shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section, or incorporated by reference into any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.